Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 796 AL 810

ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)

Murtough S, Stellakis O, Mills D, Bjourson B, Chaplin V, Chauhan D, Chipp B, Cotic M, de Villiers J, Dzahini O, Elmslie F, Evans K, Gandhi S, Hughes DA, Jin H, Panconesi D, Skowronska A, Sisodiya SM, Silva E, Stinton V, Stuart-Smith S, Tarrant S, Taylor D, Varney L, Walters JTR, Wood M, Woodley J, Dello Russo C, Pirmohamed M, Bramon E.

Br J Clin Pharmacol. 2026 Jul;92(7):1977-1990. doi: 10.1002/bcp.70576. Epub 2026 May 13.

The US Parkinson's disease community demands prevention

The Lancet Neurology.

Lancet Neurol. 2026 Jun;25(6):533. doi: 10.1016/S1474-4422(26)00173-0.

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment

Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AHV.

Lancet Neurol. 2026 Jun;25(6):602-614. doi: 10.1016/S1474-4422(26)00090-6.

Cumulative traumatic brain injury as a predictor of Parkinson's disease with sex-related differences

Lázaro-Figueroa A, Garza-Flores S, Reyes-Pérez P, Morales De Arcia A, Esquivias J, Caballero-Sánchez U, Guerra-Galicia CM, Estrada-Bellmann I, Oropeza D, Matuk-Pérez Y, Morelos-Figaredo E, Gandarilla-Martínez NA, Portillo-Sánchez A, Salinas-Barboza K, López-Pintor A, Angulo-Arrieta A, Nolasco-López M, Zayas-Del Moral A, Rentería ME, Alcauter S, Hernandez-Ponce F, González-González M, Luna-Rangel FA, Medina-Rivera A, Martinez-Ramirez D, Ruiz-Contreras AE; Mexican Parkinson's Research Network (MEX-PD).

Parkinsonism Relat Disord. 2026 Jul;148:108334. doi: 10.1016/j.parkreldis.2026.108334. Epub 2026 May 12.

Memantine as an Adjunctive Treatment for Residual Anxiety and Agitation in Early Parkinson's Disease With Depression: A Case Report

Haga T, Mori Y, Matsuda N, Sato A, Suzuki Y, Ono J, Miura I.

Neuropsychopharmacol Rep. 2026 Jun;46(2):e70129. doi: 10.1002/npr2.70129.

Effect of high, low, and asymmetric frequency stimulation of the subthalamic nucleus in Parkinson's disease

Zeng Z, Lin Z, Huang P, Pan Y, Zhang C, Sun B, Li D.

Brain Stimul. 2026 Jul-Aug;19(4):103121. doi: 10.1016/j.brs.2026.103121. Epub 2026 May 20.

Acceptability of Atropine Eyedrops Administered Sublingually for Sialorrhea Treatment Related to Neurological Conditions

Michelon H, Lefèvre-Dognin C, Paquereau J, Guidoni R, Boudy V, Ruiz F, Vallet T.

Pharmacol Res Perspect. 2026 Jun;14(3):e70250. doi: 10.1002/prp2.70250.

Redox Regulation and Mitochondrial Neuroprotection in Ischemic Stroke: The Emerging Role of DJ-1 (PARK7)

Ganamurali N, Ravikumar A, Saravanan S, Sabarathinam S.

Compr Physiol. 2026 Jun;16(3):e70182. doi: 10.1002/cph4.70182.

Baseline predictors of response to a group-based speech and communication intervention in Parkinson's disease: A secondary analysis of a randomized controlled trial

Steurer H, Schalling E, Franzén E, Gustafsson JK, Albrecht F.

J Parkinsons Dis. 2026 Aug;16(5):965-979. doi: 10.1177/1877718X261453191. Epub 2026 May 25.

Alpha-Synuclein-Specific RT-QuIC As a Tool for the Differential Diagnosis of Neurodegenerative Diseases Using Peripheral Tissues

Ix M, Dodel R, Ross JA.

Clin Chem. 2026 Aug 3;72(8):830-844. doi: 10.1093/clinchem/hvag037.

Synaptic vesicle architecture modulates α-synuclein conformation and pathogenic transitions in Parkinson's disease

Ranjan P.

Biosci Rep. 2026 Jun 17;46(6):BSR20260364. doi: 10.1042/BSR20260364.

Changes in Saccadic Hypometria over Time to Monitor Parkinson's Disease Progression

Ben-Ami E, Raveh E, Harpaz E, Riklin I, Band T, Gurevich T, Alcalay RN, Mir P, Tosin MHS, Goetz CG, Rascol O.

Pharmaceut Med. 2026 Jul;40(4):299-309. doi: 10.1007/s40290-026-00612-2. Epub 2026 May 30.

Validity of the Mini Nutritional Assessment-Short Form in Detecting Malnutrition in Parkinson's Disease: A Clinical Correlation Study

Çelik ND, Topal A, Kula AY, Çelikeloğlu E, Çetinkaya RT, Cosgun BN, Özkan S.

J Hum Nutr Diet. 2026 Jun;39(3):e70284. doi: 10.1111/jhn.70284.

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention

Leta V, Kaasinen V, Ballanger B, Cilia R.

Curr Neurol Neurosci Rep. 2026 Jun 1;26(1):29. doi: 10.1007/s11910-026-01498-y.

Glial fibrillary acidic protein (GFAP) in biofluids: analytical considerations and clinical relevance in neurodegenerative diseases

Hanin A, Quadrio I, Beaudeux JL, Lamari F.

J Neurol. 2026 Jun 1;273(6):351. doi: 10.1007/s00415-026-13896-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias